This study demonstrates the promise of G250-mAb-SPIO nanoprobe as a molecular magnetic resonance imaging probe for the early diagnositic imaging of ccRCC that overexpresses the G250 receptor. Here, CA9 is linked to nonpapillary renal cell carcinoma.